Rigel Pharmaceuticals | RIGL - PE Price to Earnings


Rigel Pharmaceuticals reported 8.61 in PE Price to Earnings for its fiscal quarter ending in March of 2025.





Pe Change Date
Amgen 18.07 1.77 Jun/2026
Anika Therapeutics 47.54 27.2 Jun/2024
Arrowhead Research 39.19 0 Jun/2026
AstraZeneca 25.34 4.25 Jun/2026
BioMarin Pharmaceutical 21.07 5.79 Jun/2026
Bristol-Myers Squibb 16.14 7.06 Jun/2026
Daiichi Sankyo 20.14 0.6 Jun/2026
Eli Lilly 32.9 7.37 Jun/2026
Halozyme Therapeutics 12.51 1.15 Jun/2026
Intrexon 7.54 221.44 Dec/2021
Ionis Pharmaceuticals 396.15 79.28 Sep/2022
Ligand Pharmaceuticals 84.31 27.81 Jun/2026
Neurocrine Biosciences 22.1 5.99 Jun/2026
Pfizer 11.48 2.16 Jun/2026
Regeneron Pharmaceuticals 15.46 9.68 Jun/2026
Rigel Pharmaceuticals 8.61 8.4 Mar/2025
Veracyte 42.77 17.88 Jun/2026